Atara Biotherapeutics ATRA Balance Sheet (2012-2026)

NASDAQ ATRA
$8.23 +0.13 (+1.60%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Atara Biotherapeutics Quarterly Balance Sheet

Periods 54 quarters
Latest Sep 2026

Atara Biotherapeutics reported total assets of $18.61M and total liabilities of $56.51M for the quarter ended Sep 2026, down 38.3% year over year. This balance sheet covers 54 quarters of results from Dec 2012 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Dec2012 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
106.08M101.67M70.69M65.11M92.94M48.74M45.90M64.79M25.84M35.09M31.31M46.45M25.03M13.84M16.90M5.74M8.48M8.40M3.22M4.06M
Short-term InvestmentsInvestments (Current)
264.98M200.14M260.62M200.29M149.88M156.67M107.74M37.62M25.88M11.15M3.98M20.74M17.47M5.42M7.97M6.65M5.86M
Cash & Current Investments
371.07M301.81M331.31M265.40M242.82M205.41M153.64M102.41M51.73M46.24M35.29M67.19M42.50M13.84M22.32M13.71M8.50M8.40M9.90M9.90M
Receivables - NetNet Receivables
0.99M0.67M0.64M0.25M40.22M0.40M0.51M0.16M34.11M35.83M2.42M1.34M1.48M8.88M1.91M1.25M0.32M0.69M
Receivables
0.99M0.67M0.64M0.25M40.22M0.40M0.51M0.16M34.11M35.83M2.42M1.34M1.48M8.88M1.91M1.25M0.32M0.69M
Raw Materials
1.21M1.32M2.75M2.42M2.34M4.36M3.64M1.65M0.96M
Work In Process
0.37M4.02M5.11M4.17M7.37M11.72M15.11M12.33M9.69M
Inventory
1.59M5.34M7.86M6.59M9.71M16.08M18.75M13.98M10.66M
Current Deferred Tax AssetsCurrent Deferred Tax
Prepaid Assets
12.37M11.57M13.69M16.05M10.31M12.89M10.16M9.39M6.18M8.13M5.80M9.21M10.12M4.32M2.45M2.81M2.48M3.81M3.34M0.71M
Current Assets
384.62M314.39M346.98M283.05M295.08M224.18M172.32M118.70M101.87M106.43M62.41M91.86M64.89M27.18M24.77M18.43M12.21M12.17M13.53M11.31M
Non-Current Assets
Construction in Progress
6.33M0.02M0.04M0.03M0.52M0.71M0.24M0.16M0.02M0.03M
Property, Plant & Equipment (Net)PP&E (Net)
53.78M9.11M8.33M7.27M6.30M5.85M5.35M4.63M3.86M2.99M2.32M1.66M1.29M0.29M0.18M0.15M0.07M0.06M0.04M0.04M
Intangibles
Goodwill & Intangibles
Long-Term Deferred Tax
Other Non-Current Assets
3.57M56.15M8.53M8.47M7.02M6.91M6.58M6.29M4.84M3.87M3.61M3.36M3.10M2.84M0.93M0.88M0.89M0.89M0.77M0.76M
Non-Current Assets
83.51M82.89M89.14M85.27M81.34M77.90M74.12M70.09M63.64M58.84M54.87M50.85M44.20M34.86M12.13M11.74M8.02M7.82M7.49M7.29M
Assets
468.13M397.28M436.12M368.32M376.42M302.08M246.44M188.79M165.50M165.27M117.28M142.71M109.10M62.04M36.90M30.17M20.24M20.00M21.02M18.61M
Liabilities
Current Liabilities
Accounts Payables
17.37M11.95M12.80M11.30M6.87M5.07M4.14M6.51M3.68M2.85M5.25M2.15M4.37M1.38M1.76M0.32M0.13M0.64M0.82M0.76M
Payables
17.37M11.95M12.80M11.30M6.87M5.07M4.14M6.51M3.68M2.85M5.25M2.15M4.37M1.38M1.76M0.32M0.13M0.64M0.82M0.76M
Accumulated Expenses
5.96M7.44M7.46M11.93M9.06M19.01M18.20M11.19M8.06M6.03M9.50M4.78M2.55M1.80M1.75M2.16M2.28M
Other Accumulated Expenses
13.45M13.99M19.78M22.81M24.99M23.77M25.17M23.97M31.83M33.05M26.15M23.64M20.16M24.14M7.67M4.65M2.98M2.94M3.46M3.69M
Short term Debt
Current Leases
0.17M0.83M0.83M0.86M0.89M0.92M0.95M0.98M1.01M1.04M1.07M
Current Taxes
Current Deferred Revenue
40.76M50.94M1.67M2.66M8.00M9.92M11.95M11.61M77.83M123.15M107.58M116.34M95.09M15.98M1.61M1.01M0.72M0.68M0.78M0.51M
Total Current Liabilities
105.79M101.56M65.69M72.24M78.92M67.88M74.55M79.09M142.23M180.69M148.27M155.98M134.57M47.89M14.56M18.06M14.92M5.65M6.85M6.57M
Non-Current Liabilities
Capital Leases
Non-Current Deferred Revenue
55.71M45.00M43.33M42.34M77.00M78.04M75.57M73.93M37.56M0.72M0.57M0.47M
Preferred Stock Liabilities
Liabilities from Discontinued OperationsLiabilities from Discont. Ops
8.33M30.24M
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax
Operating Leases
25.52M17.45M64.00M61.07M58.06M54.92M51.75M48.51M45.69M42.20M38.70M35.24M29.91M26.71M15.43M15.01M9.35M9.08M8.78M8.48M
Other Non-Current Liabilities
1.50M0.62M5.63M5.55M5.56M5.18M5.02M4.85M39.71M4.40M4.17M3.97M42.28M43.00M42.53M43.41M44.22M43.30M43.42M42.56M
Total Non-Current Liabilities
187.01M172.35M173.02M175.65M244.22M231.95M233.96M234.78M26.57M259.18M223.99M229.28M164.11M74.11M29.42M23.39M14.52M14.01M14.60M13.95M
Total Liabilities
188.51M172.96M178.64M181.20M249.78M237.12M238.99M239.63M66.27M263.58M228.15M233.25M206.38M117.11M71.94M66.80M58.74M57.31M58.02M56.51M
Shareholder's Equity
Total Debt
Common Equity
279.61M224.32M257.48M187.11M126.64M64.96M7.45M-50.84M99.23M-98.31M-110.87M-90.54M-97.28M-55.07M-35.04M-36.63M-38.50M-37.31M-37.00M-37.90M
Liabilities and Shareholders Equity
468.13M397.28M436.12M368.32M376.42M302.08M246.44M188.79M165.50M165.27M117.28M142.71M109.10M62.04M36.90M30.17M20.24M20.00M21.02M18.61M
Retained Earnings
-1,464.72M-1,552.83M-1,534.36M-1,618.45M-1,693.02M-1,767.80M-1,838.90M-1,908.70M-1,969.15M-2,000.90M-2,019.95M-2,041.86M-2,054.55M-2,016.54M-2,014.16M-2,018.46M-2,021.87M-2,026.01M-2,030.84M-2,033.07M

Atara Biotherapeutics Balance Sheet API

Pull Atara Biotherapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ATRA&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY